2011 Gordon Research Conference on Tuberculosis Drug Development
2011 Gordon Research Conference on Tuberculosis Drug Development
批准号:
8125495
负责人:
DAVID R SHERMAN
金额:
$0.8万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-06-01 至 2011-10-31
关键词:
AcademiaAffectAreaBacillus (bacterium)Cause of DeathChemistryClinical ResearchClinical TrialsDiseaseDisease ResistanceDrug resistanceDrug-sensitiveEventFundingFunding AgencyIndividualIndustryInternationalItalyLearningMedicineMicrobiologyPharmaceutical PreparationsPharmacologyRequest for ApplicationsResearchResearch PersonnelTestingTrainingTuberculosisWorkabstractingdrug candidatedrug developmentdrug discoveryexperiencegraduate studentimprovedmeetingsnew technologyprogramssymposiumtuberculosis drugstuberculosis treatment
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This application seeks partial support for the 2011 Gordon Research Conference (GRC) on Tuberculosis (TB) Drug Development to be held in Il Ciocco, Italy from July 3rd - 8th. This biennial event is the most important global conference bringing together researchers from both academia and industry to focus on this problem. Treatment of TB remains a continuing challenge particularly with the increasing problem of drug resistance. New treatments could dramatically improve the results of therapy of both drug-sensitive and drug-resistant disease and compounds with new modes-of-action are being actively sought for this reason. TB drug discovery is an extremely vigorous area of research and is increasingly attracting investigators with diverse backgrounds, including microbiology, chemistry, pharmacology, medicine and clinical research. The 2011 GRC on TB Drug Development will provide an opportunity for new investigators to understand the challenges in the field and for experienced researchers to discuss the latest findings at a particularly critical juncture.
PUBLIC HEALTH RELEVANCE: Tuberculosis remains one of the leading causes of death in the world and rates of disease continue to climb. New treatments for tuberculosis could cure this disease and limit its spread. Here we request funding for the major biennial scientific meeting in this area, the 2011 Gordon Research Conference on Tuberculosis Drug Development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Drug tolerance, bacterial heterogeneity and adverse TB treatment outcomes
-
批准号:10665037
-
项目类别:
-
资助金额:$13.32万
-
财政年份:2021
-
负责人:DAVID R SHERMAN
-
依托单位:
A multifactorial pipeline to dissect combinatorial drug efficacy in Tuberculosis
-
批准号:10117593
-
项目类别:
-
资助金额:$73.08万
-
财政年份:2021
-
负责人:DAVID R SHERMAN
-
依托单位:
Drug tolerance, bacterial heterogeneity and adverse TB treatment outcomes
-
批准号:10493290
-
项目类别:
-
资助金额:$14.37万
-
财政年份:2021
-
负责人:DAVID R SHERMAN
-
依托单位:
A multifactorial pipeline to dissect combinatorial drug efficacy in Tuberculosis
-
批准号:10669196
-
项目类别:
-
资助金额:$72.12万
-
财政年份:2021
-
负责人:DAVID R SHERMAN
-
依托单位:
A multifactorial pipeline to dissect combinatorial drug efficacy in Tuberculosis
-
批准号:10465068
-
项目类别:
-
资助金额:$70.51万
-
财政年份:2021
-
负责人:DAVID R SHERMAN
-
依托单位:
Drug tolerance, bacterial heterogeneity and adverse TB treatment outcomes
-
批准号:10271651
-
项目类别:
-
资助金额:$56.87万
-
财政年份:2021
-
负责人:DAVID R SHERMAN
-
依托单位:
Drug tolerance, bacterial heterogeneity and adverse TB treatment outcomes
-
批准号:10907961
-
项目类别:
-
资助金额:$33.99万
-
财政年份:2021
-
负责人:DAVID R SHERMAN
-
依托单位:
Project 2: Response to Treatment
-
批准号:10339374
-
项目类别:
-
资助金额:$74.61万
-
财政年份:2018
-
负责人:DAVID R SHERMAN
-
依托单位:
Parallel Microscopic Determination of Fitness (PMDF) to Assess Growth and Viability of Mycobacterium tuberculosis
-
批准号:9089849
-
项目类别:
-
资助金额:$23.63万
-
财政年份:2015
-
负责人:DAVID R SHERMAN
-
依托单位:
Bacterial Determinants of TB Progression
-
批准号:8577274
-
项目类别:
-
资助金额:$58.47万
-
财政年份:2013
-
负责人:DAVID R SHERMAN
-
依托单位:
Data Management and Resource Dissemination Core
-
批准号:8577291
-
项目类别:
-
资助金额:$17.88万
-
财政年份:2013
-
负责人:DAVID R SHERMAN
-
依托单位:
2013 Tuberculosis Drug Development GRC
-
批准号:8520841
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2013
-
负责人:DAVID R SHERMAN
-
依托单位:
A Novel Clock to Monitor M. tuberculosis in vivo
-
批准号:7844978
-
项目类别:
-
资助金额:$24.1万
-
财政年份:2009
-
负责人:DAVID R SHERMAN
-
依托单位:
A Novel Clock to Monitor M. tuberculosis in vivo
-
批准号:7574365
-
项目类别:
-
资助金额:$26.47万
-
财政年份:2009
-
负责人:DAVID R SHERMAN
-
依托单位:
Hypoxia, Latency and Reactivation in M.tuberculosis
-
批准号:7016314
-
项目类别:
-
资助金额:$32.87万
-
财政年份:2002
-
负责人:DAVID R SHERMAN
-
依托单位:
Hypoxia, Latency and Reactivation in M.tuberculosis
-
批准号:6655602
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2002
-
负责人:DAVID R SHERMAN
-
依托单位:
Hypoxia, Latency and Reactivation in M.tuberculosis
-
批准号:6857094
-
项目类别:
-
资助金额:$33.68万
-
财政年份:2002
-
负责人:DAVID R SHERMAN
-
依托单位:
Hypoxia, Latency and Reactivation in M.tuberculosis
-
批准号:6450621
-
项目类别:
-
资助金额:$16.66万
-
财政年份:2002
-
负责人:DAVID R SHERMAN
-
依托单位:
Hypoxia, Latency and Reactivation in M.tuberculosis
-
批准号:6725521
-
项目类别:
-
资助金额:$35.1万
-
财政年份:2002
-
负责人:DAVID R SHERMAN
-
依托单位:
Hypoxia, Latency and Reactivation in M tuberculosis
-
批准号:6346504
-
项目类别:
-
资助金额:$32.15万
-
财政年份:2001
-
负责人:DAVID R SHERMAN
-
依托单位:
海外基金